Cystic fibrosis: management and monitoring of respiratory manifestations
You must score at least 70% in this module to pass. Ensure you have read ‘Cystic fibrosis: management and monitoring of respiratory manifestations’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
0 of 15 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 15 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Which of the following statements regarding cystic fibrosis is incorrect:CorrectIncorrect
Cystic fibrosis is the result of CFTR protein absence and/or dysfunction. CFTR is found in many organs in the body. Which of the following is not a manifestation of cystic fibrosis:CorrectIncorrect
CFTR modulators have radically changed the management of cystic fibrosis. Which of the following statement regarding CFTR modulators is false:CorrectIncorrect
CFTR modulators have been shown to reduce mucus viscosity. Which of the following is not a side effect of CFTR modulators?CorrectIncorrect
Owing to the characteristic viscous mucus found in the lungs, respiratory infection is more common. Which of the following is not a common pathogen found in people with cystic fibrosis?CorrectIncorrect
Respiratory infection is more common in cystic fibrosis (CF). Which of the following statements regarding respiratory infection in CF is false:CorrectIncorrect
Long-term oral antibiotics are commonly prescribed in cystic fibrosis. Which of the following statement regarding long-term oral antibiotics is incorrect:CorrectIncorrect
Nebulised antibiotics are used to treat respiratory infection with Pseudomonas aeruginosa. Which of the following statements about eradicating Pseudomonas aeruginosa infections is incorrect:CorrectIncorrect
Nebulised and inhaled antibiotics are used in the treatment of chronic respiratory infection with Pseudomonas aeruginosa. Which of the following statements regarding nebulised and inhaled antibiotics for the treatment of Pseudomonas aeruginosa is incorrect:CorrectIncorrect
If all Pseudomonas aeruginosa eradication attempts fail, then the patient is classed as being chronically infected. Which antibiotic is licensed for continuous use for chronic Pseudomonas aeruginosa infection?CorrectIncorrect
Combined antimicrobial resistant mechanisms mean that over time, chronic infections in cystic fibrosis can become harder to treat with conventional treatments. Which of the following combination therapies would be considered for use in this instance?CorrectIncorrect
Pulmonary exacerbations are the primary cause of hospital admissions for those with cystic fibrosis. Which of the following statement about pulmonary exacerbations is incorrect:CorrectIncorrect
Antimicrobials are used to treat pulmonary exacerbations. Which of the following statements about the use of antimicrobials in pulmonary exacerbations of cystic fibrosis is false:CorrectIncorrect
Chest clearance is fundamental part of the treatment of cystic fibrosis. Which of the following statements about chest clearance is incorrect:CorrectIncorrect
Pulmonary function of people with cystic fibrosis should be monitored at each clinic visit. Which of the following statements about respiratory secretion samples is incorrect?CorrectIncorrect